-
August 16: The Week in Cancer News
A radiation oncologist draws on her personal experience as she researches financial toxicity, and the U.S. Food and Drug Administration issues a third tissue-agnostic approval.
by Kate Yandell
-
August 9: The Week in Cancer News
A liquid biopsy test is effective in detecting a cancer biomarker, Medicare opts to cover CAR-T cell therapies, and an e-cigarette maker spends millions to defeat a ban on sales in San Francisco.
by Kevin McLaughlin
-
August 2: The Week in Cancer News
The U.S. Food and Drug Administration for the first time approves an immune checkpoint inhibitor for treatment of esophageal cancer, and a two-drug combination shows promise for treating chronic lymphocytic leukemia.
by Kate Yandell
-
July 26: The Week in Cancer News
The U.S. Food and Drug Administration requests a recall of textured breast implants, and a study indicates BRCA2 mutations are associated with non-Hodgkin lymphoma.
by Kate Yandell
-
July 19: The Week in Cancer News
A study sheds light on the effects of hurricanes on cancer patients receiving radiation therapy, and the Biden Cancer Initiative suspends operations.
by Kate Yandell and Bradley Jones
-
July 12: The Week in Cancer News
A combination of three targeted therapies can lengthen survival for some patients with metastatic colorectal cancer, and patients receiving stem cell transplants can benefit from shingles vaccines.
by Kate Yandell
-
June 28: The Week in Cancer News
A study indicates that many African Americans who could benefit from lung cancer screening are not eligible, and an oncologist writes about his experiences with medical aid in dying.
by Kate Yandell
-
June 21: The Week in Cancer News
A study shows that more than a third of U.S. cancer survivors experience chronic pain, and the U.S. Food and Drug Administration approves another immunotherapy for treatment of small cell lung cancer.
by Kate Yandell
-
June 14: The Week in Cancer News
A physician writes about the long-term effects of her treatment for Hodgkin lymphoma in the 1960s, and the U.S. Food and Drug Administration approves an immunotherapy drug as an initial treatment for metastatic head and neck cancer.
by Kate Yandell
-
June 7: The Week in Cancer News
A study finds that a targeted therapy approved to treat advanced breast cancer lengthens survival, and data indicate that Medicaid expansion has helped ease racial disparities in access to cancer care.
by Kate Yandell
Cancer Talk
Many People Don’t Get Colonoscopy After Receiving Abnormal Blood Tests
About half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles